Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library

School of Medicine

January 2016

The Role Of Oxytocin In Modulating Neural
Oscillations In Nulliparous Women
Xiaoyue Mona Guo
Yale University

Follow this and additional works at: https://elischolar.library.yale.edu/ymtdl
Recommended Citation
Guo, Xiaoyue Mona, "The Role Of Oxytocin In Modulating Neural Oscillations In Nulliparous Women" (2016). Yale Medicine Thesis
Digital Library. 2053.
https://elischolar.library.yale.edu/ymtdl/2053

This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.

The Role of Oxytocin in Modulating Neural Oscillations in Nulliparous Women

A Thesis Submitted to the

Yale University School of Medicine

in Partial Fulfillment of the Requirements for the
Degree of Doctor of Medicine

by

Xiaoyue Mona Guo
2016

ABSTRACT
THE ROLE OF OXYTOCIN IN MODULATING NEURAL OSCILLATIONS IN NULLIPAROUS
WOMEN. Xiaoyue Mona Guo, Helena J.V. Rutherford, Linda C. Mayes. Child Study Center,
Yale University, School of Medicine, New Haven, CT.

The hormone oxytocin (OT) has been implicated in social cognition and behavior as well
as in modulating important affiliative relationships such as parenting; meanwhile,

intranasal OT administration is gaining popularity as a means to modulate neural

activity in brain regions during experimental tasks. However, the neural mechanisms
underscoring the changes associated with OT administration have yet to be fully

elucidated. Using electroencephalography (EEG), this thesis project aims to further our

understanding of how OT affects brain activity and response to infant cues. In a doubleblind placebo controlled design, OT’s effect on resting-state neural oscillations and

event-related potentials (ERPs) to face stimuli were examined in a cohort of nulliparous
women of childbearing age. Specifically, we examined the effects of intranasal OT on

delta, beta, and delta-beta coupling during the resting state, and the amplitudes of the

ERP components N170, P300, and the Late Positive Potential (LPP) to infant and adult
faces. Prior work has suggested that cross-frequency coupling may be a useful way to
study cognitive processing, whereas the N170, P300 and LPP are all components

involved in the processing of facial and emotional stimuli. We found that OT, relative to

placebo, decreased delta-beta coupling across multiple brain regions; ERP data showed

that OT administration led to an increased amplitude of the P300 component to infant
faces compared with adult faces. Taken together, these findings demonstrate that OT

administration may lead nulliparous women to allocate greater attentional resources to
infant faces than adult faces via a neural mechanism captured by delta-beta coupling.
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INTRODUCTION
Over the past decade, oxytocin (OT) has made news headlines from “OT makes people

more trusting” to “Hormone OT jump-starts maternal behavior” [Data Source: Google

Trends (www.google.com/trends)]. This so-called “love hormone” has gained attention
in the research field for both its seeming influence on an increasing myriad of human
behaviors and its potential for use in clinical populations. However, despite the fourfold increase in the number of publications over the past decade on OT and social

cognition or behavior [1], there continue to be an absence of knowledge about OT’s

basic neurophysiological effects. What’s more, notably lacking are studies on female

participants due to the difficulties of controlling for hormonal interactions.

This thesis will provide a brief overview of the roles OT may play in social contexts and
of how electroencephalography (EEG) can help inform this body of research,

particularly for women. The studies described will investigate how OT administration
affects brain responses in a cohort of healthy nulliparous women as measured by EEG
both at rest and in response to social and nonsocial cues.
Physiologic Roles of Oxytocin

Derived from the Greek word oxutokia (oxus or ‘sharp’ + tokos or ‘childbirth’ = ‘sudden
delivery’), OT is a neuropeptide produced by the hypothalamus that acts as both a

peripheral hormone and a central neurotransmitter. OT belongs to an ancient class of

molecules known as nonapeptides, which are found in virtually every vertebrate

phylum, with a lineage that can be traced through invertebrates. Despite the different

types of nonapeptides within diverse species, they all are usually expressed selectively
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in the brain and gonads (with OT shown to be synthesized further in somatic organs
such as the heart, thymus and gastrointestinal tract [2]), are influenced by gonadal

steroids, and are important for social behavior [3]. Much of what we understand of

oxytocin’s physiologic activity are from animal models, and very early studies suggested
the importance of OT and the OT receptor in triggering critical aspects of pair bond

formation and maternal behavior in rodents [3]–[5] which have since been replicated in
higher-order mammals and primates [5], [6].

In humans, OT has a few well-described natural effects: in women, OT induces uterine

contractions during parturition and is involved in milk release during breastfeeding.

For both men and women, OT is released during sexual stimulation and orgasm, may
reduce urine volume and induce natiuresis through co-activation of vasopressin

receptors, and is involved in the modulation and regulation of the hypothalamic-

pituitary-adrenal (HPA) axis [3]. On a cellular level, oxytocinergic neurons project to

limbic, mid-, and hindbrain structures including the hippocampus and amygdala; they

also have indirect effects on the activity of higher cortical functioning and the synaptic

transmission of other neurotransmitters, including serotonin [7]–[9].

Importantly, there is a greater understanding of how the OT system is endogenously

mediated by changes in OT receptors, whether via dynamic regulation in density and
location by hormones like estrogen, or genetic and epigenetic differences between

individuals. Pregnancy is a leading example, when elevated estrogen levels prime the

maternal brain for increased synthesis of both OT and OT receptors, and lead to marked
increases in OT receptor density in the uterus, mammary myoepithelium, and

hypothalamus [10]. More recently, single nucleotide polymorphisms in the OT receptor
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gene have been suggested to affect the efficiency of OT signaling in individuals [11],

particularly with regards to caregiving behaviors such as parental touch [12] or
response to infant faces [13]. However, a meta-analysis found that the direct

social/behavioral impact of these genetic variances are inconsistent and small in

magnitude [14], with increasing research now focusing on epigenetic modifications of
the receptor gene via early childhood experiences [15], [16].
Influence of Intranasal Oxytocin on Social Behavior

Given these traditional associations of OT with affiliative behaviors, it is not surprising

that OT has been broadly mapped onto human neurobiology with its actions translated

towards affecting important human relationships (see reviews [10], [17]). To assess

experimentally the central actions of OT in humans, intranasal administration has

gained wide support and popularity of use. While minimal pharmacokinetic

information exists on intranasal OT, a number of studies evidenced elevated levels of

salivary OT for up to seven hours post administration [18]–[20]. More importantly, the

nasal route circumvents the blood-brain barrier and leads to replicable behavioral and

functional changes [15], [21]. However, it is worth noting that this methodology is not

without its criticisms; taking into account the prevalence of somatic OT receptors and
that a modest percentage of intranasal OT reaches the cerebral spinal fluid compared

to the peripheral circulation, care needs to be taken in interpreting behavioral results

as centrally versus peripherally driven [22].

Increasingly, OT has been associated with various aspects of positive human sociability
including supporting partner communication and interactions [23], [24], improving
emotion recognition in faces [25], [26], and increasing trustworthiness and trust
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building [27]–[29]. In healthy populations, these results translate to a promise of stress

reduction and anxiolysis [30], [31] as well as enhanced prosocial behavior [11].

Coupled with clinical research showing that plasma levels of OT are inversely related

to depressive [32] and psychotic [33] symptomology, therapeutic considerations have
risen for OT use in a host of patient intervention protocols from autism and

schizophrenia to post-traumatic stress disorder and depression [34]–[37]. The crux of

these treatment effects may lie in OT’s anxiolytic properties, as it decreases an

individual’s aversion to negative internal or external stimuli [15].

However, despite excitement about OT’s potential pharmacologic role, little is known
about the neural basis underlying these effects, and inconsistencies abound between
various studies in dosages used (from 2 IU to 320 IU) and the durations to wait after

spray administration before measuring changes in the dependent variables [10], [15],

[38]. Moreover, there is burgeoning evidence that OT also has negative influences such
as increasing feelings of exclusion [39], and that the behavioral presentation depends
on the individual. The end-effect of OT appears to be moderated by environmental

contexts, personal characteristics, and early childhood experiences. Specifically, OT

plays a stronger role when considering in-group situations, and in participants with
lower attachment anxiety and supportive parenting backgrounds [15], [40].

Differential Oxytocin Effects on Women
Oxytocin and the Mother

Encompassing all the above described affiliative behaviors of trust and empathy is the

act of parenting. Unsurprisingly, the earliest evidence suggesting OT’s influence beyond
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that of reproduction and parturition physiology was the stimulation of a nurturing,
maternal phenotype in virgin rats that were centrally administered with OT [41].

Multiple human and animal studies since have supported this observation and

implicated OT in having a key role in the formation and development of the infant-

parent bond [6], [42]. For example, affectionate and stimulatory parenting behaviors
are correlated with OT levels in new mothers and fathers, respectively [10], and

securely attached mothers have a stronger OT response following a play interaction

with their child as compared to insecurely attached mothers [43]. Moreover, a steady
rise in OT levels from the first through third trimester in a pregnant woman is

correlated with higher self-reported bonding scores to her unborn infant [44]. There

also appears to be a genetic basis underlying the parental OT pathway, with low-risk OT
receptor alleles corresponding with more sensitive parental care [12], and stronger

preference for infant faces [13], [45].

One way to experimentally study parenting is through examining and comparing the

response to infant versus non-infant cues. This predilection for infant cues (faces and

cries) that seems to instinctively trigger feelings of protection and caretaking may arise
from an innate positive affect towards the “baby schema,” a collection of infantile

characteristics like big eyes and round features [46]. Multiple studies show individuals

having greater responses in brain regions associated with face processing, attention,

and reward when viewing infant versus adult faces; the use of images or sounds from a
parent’s own infant further enhances these responses (see review [47]). With its

association with affiliative behavior, intranasal OT administration also unsurprisingly
increases sensitivity to infant cues [45], [48].
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More recent work suggests that a number of individual differences, including substance
use [49] and depression [50] may also affect the neural response to infant cues. As

stress and addiction both impact prefrontal cortical function [51], [52] these states

may have detrimental effects on executive function as it relates to parenting behavior

[53]. Evidence further shows OT to have a bidirectional relationship with HPA activity

[54] and drug exposure [55]. In rodents, chronic OT administration leads to a

reduction of the acute stress response [56]; OT has also been shown to be released by
the heart and vasculature, suggesting a role in the modulation of cardiac activity and

vascular tone [57], [58]. Accordingly, in mothers 2 – 6 months postpartum, the amount
of plasma OT following stress induction was related to lower cardiac and vascular

reactivity and increased levels of norepinephrine [59]. This attenuation of the HPA axis

by OT is further observed with lactating mothers, where a rise in OT following

breastfeeding is inversely related to ACTH and cortisol levels, and the act of

breastfeeding can decrease HPA responses to a stress exposure [44]. These studies

suggest potential benefits of OT in modulating the physiological stress responses that

are critical factors in parenting; they further suggest that OT may have a wider
regulatory function than previously thought.

More broadly, global gray matter volume has been shown to significantly increase in

mothers from 2 – 4 weeks to 3 – 4 months postpartum [60], supporting a notion that
cortical reorganization over the postpartum period serves to facilitate parenting

behavior and the orientation of attention and perception towards the infant. The exact
neurological basis of parenting, however, is still unknown. An area of accumulating
evidence is the idea that that reward neural circuits in mothers are recruited when
they are engaged with infant cues, particularly of their own infants [61]. Several
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studies have shown the importance of increasing orbitofrontal cortex activity in various
aspects of parenting, including when listening to infant cries versus white noise [62],

[63], viewing pictures of own infant faces versus unknown infant faces [64], perceiving

infant faces as compared to adult faces [65], and distinguishing maternal from

romantic attachment [66]. OT administration has been shown to directly affect neural
activation of similar regions, with a recent meta-analysis of fMRI studies on mother-

infant interactions finding greater activation of the left insula but decreased activation
of the dorsomedial frontal cortex in the maternal brain [67].

Oxytocin in Nulliparous Women

Despite rich research on the maternal-infant relationship, it is difficult to understand
the changes that occur in a woman’s affiliative processing abilities throughout the

course of pregnancy and into early and late-postpartum periods. This is made even

more complicated by further differences in the neural response to infant cues while

comparing parents to non-parents [68], suggesting a unique parental neurologic state
that could be in part modulated by OT. Multiple studies describe how intranasal OT
administration modifies a nulliparous woman’s neural and behavioral responses to
infant cues to being more similar to those of a postpartum woman. For instance,

nulliparous participants given OT have increased empathy and decreased negative

affect towards a crying infant, and report higher arousal by photos of infants [69]–[71].

The OT literature has burgeoning data supporting the existence of underlying sexual
dimorphism modifying OT’s physiologic effects and the importance of appreciating
these sex-dependent effects particularly for translational research [72]. Indeed, a
recent rodent study suggested a direct link between sexual dimorphism in OT-

8

producing areas of the brain and sex-specific behaviors. By optogenetically turning on a

group of hypothalamic neurons, the researchers were able to increase a virgin female
rats’ pup retrieval behavior and circulating OT levels in rats of both sexes, providing

new causative data on gender differences in social or reproductive behaviors [73]. In

human women compared to men, OT is associated with almost opposite neural imaging

findings particularly in the temporal lobes and subcortical areas such the amygdala
[38], [74]. The neuropeptide has also been shown to reduce self-reported anxiety

measures in women who use emotion-oriented coping mechanisms but not men [75],

and generally leads to more “tend and befriend” traits instead of the “fight and flight”

responses of the male participants [76], [77]. Similarly, there is some indication that OT

makes a male’s neural responses, especially older men’s, more similar to that of females
[78], [79].

Despite gender being a well-explored moderator of OT effects on social cognition, a

significant limitation to our understanding of maternal-infant relationships is a scarcity

of data using non-maternal female populations. This bias is evident in the 44

publications using intranasal OT prior to 2010, where 32 used an all-male participant

pool and only one used an all-female group [17]. In order to avoid potential interactions
and confounding by hormonal variances, researchers often do not recruit female

participants, and thus our foundation of OT-related knowledge has predominantly been

anchored on male-oriented studies. For the studies that do use females and males, some

show a lack of gender differences (i.e., [80]–[82]), possibly due to differences in study

design and inclusion/exclusion criteria of the participants (including but not limited to
OT dosage, oral contraceptive use, menstrual cycle, and parity).
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A well-controlled, mechanistic understanding of OT’s effects on the nulliparous female
brain thus still requires study. This thesis employs a female-only sample given the

limited knowledge of OT effects on neural activity in this group, to help augment our
sex-specific appreciation of OT modulation.

Assessing Neural Responses to Oxytocin Using Electrophysiology
Given the sometimes conflicting and inconsistent results of intranasal OT research,

there is growing interest towards exploring its effects using behavioral and functional
neuroimaging [83]. The majority of these intranasal OT studies have employed

functional magnetic resonance imaging (fMRI), a methodology relying on changes in

blood oxygenation to determine brain activity [38]. However, electroencephalography
(EEG) provides a valuable alternative to imaging data by enabling a direct index of

neuronal activity through measuring post-synaptic potentials of cortical pyramidal

neurons [84]. The few studies using EEG have mostly shown that OT administration
mainly alters cortical activity during social tasks, specifically, and that these neural

effects correspond with performance on these tasks [38]. Through complementing the

spatial resolution of fMRI findings with the temporal resolution of EEG studies, a more
comprehensive picture of the neurophysiology behind OT administration on human
cognitive and social behavior can be formed.
Delta-Beta Coupling

In EEG, tightly coupled neural correlates can be measured as oscillations of varying

frequency: slow waves (i.e., delta, theta) are thought to reflect subcortical emotion and
motivational processes, whereas fast waves (i.e., alpha, beta, gamma) are thought to
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reflect more cortical cognitive control processes [85]. Prior research has found no

changes in the neural activity of individual frequency bands with OT administration
when EEG was recorded at rest without social stimuli or tasks [38], [86]. As such,

interest has increasingly veered away from the study of individual frequency bands to

focus on cross-frequency coupling, measured as correlations between the amplitudes of
slow- and fast-wave oscillations, to understand complex brain interactions more fully.

Indeed, this method may be more sensitive to the complexities of OT effects [87].

In particular, amplitude-amplitude coupling between delta and beta activity may

represent a synchronization or interface between emotional or motivational systems

and higher-order cognition, given the likely subcortical and cortical generators of these
oscillations, respectively [85]. Support for this approach can be garnered from studies

examining delta-beta correlations when the interplay of affect and cognition may be

compromised, particularly in relation to increased levels of stress and anxiety. For

example, there is a positive association between the strength of delta-beta coupling and
basal cortisol levels [88]; intranasal administration of cortisol also increases this

correlation, an effect that was amplified in participants with higher levels of behavioral
inhibition [89]. Furthermore, delta-beta coupling is increased in more anxious

individuals and decreased after the treatment of anxiety [90]. Consequently, given the
previously described properties of OT in decreasing stress and anxiety, OT

administration may modulate cross-frequency coupling on EEG despite not affecting the
activity of individual frequency bands.

In the first portion of the current study, EEG served as a viable tool for evaluating and

understanding the underlying neural mechanisms of OT in healthy nulliparous women
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in the absence of any social or behavioral task. Through observing OT effect on the

amplitudes of delta, beta, and delta-beta coupling at rest, we can directly examine the

role of OT at the neural interface of emotional or motivational systems and cognition

[85]. Given the aforementioned relationship of delta-beta coupling with anxiety, it was

hypothesized that administration of intranasal OT, relative to placebo, would decrease

delta-beta coupling, consistent with OT’s association with decreasing stress and anxiety.

As previous research has not shown changes in delta and beta oscillations following
hormonal manipulations, it was anticipated that these individual frequency bands
would similarly be unaffected by OT administration.

Event-Related Potentials to Infant Faces: N170, P300, LPP
Evoked or event-related potentials (ERPs) are another way of observing the brain’s
electrical potentials as elicited by specific sensory events. Whereas the rhythmic

oscillations of EEG show a more general state of activity, ERPs enable the analysis of
the synchronized processes of a population of neurons underlying perceptual,
attentional, and cognitive responses in a time-locked manner.

Characteristic ERP waveforms are associated with different visual stimuli; faces are

particularly prominent in the literature as eliciting a stereotypical response. The N170,
a negative ERP component 170ms after the presentation of the stimulus, is an early

marker of the structural encoding of human faces [91], [92]. Correlating with fMRI, the
N170 is most prominent over brain areas implicated in face processing (e.g.,the
fusiform gyrus) [34]. Infant faces have been shown to differentially affect this

component compared to adult faces in parents and non-parents alike, while being

modulated by bond formation between a parent and their infant [93]. Indeed, the N170
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response is affected by individual differences in sensitivity to infant cues such as

parental status and mood [50], [94]. It has also been shown to be modulated by the

infant’s emotional expression (particularly of distress), although the literature is mixed

regarding how the amplitude of the N170 changes in response to the cue versus other
parental characteristics like depressive symptomology [95].

The P300 or P3 positivity component is another well-described ERP configuration

triggered by detection of or attention to an improbable, ‘oddball’ stimulus [92].

Compared with the immediacy of components like that N170 that correspond with the
initial perception of a stimulus, the P300 is associated with a later stage of cognitive
processing that requires more long-term memory and recognition [96]. Overall, it

appears to reflect attention allocation towards motivationally salient and task-relevant
stimuli, as the P300 amplitude is directly related to subjective perceptions of the

probability of and attentional engagement to the stimulus [96], [97]. Crucially, P300

activity has been evidenced to be sensitive to prosocial behavior [98], and emotional

stimuli in particular leads to a sustained P300 dubbed the late positive potential (LPP).
More specifically, the LPP reflects a conscious allocation of attention to, and presumed
continuous processing of, motivationally significant emotional stimuli [97].

Both the P300 and LPP have been explored in the context of the presumed relative
importance of processing infant cues [95]. The P300 is greater in amplitude when

mothers are tested with cues of their own versus an unknown infant [93], [99] and
greater with distressed infant faces [68]. For the LPP, mothers who were more

accurate in face recognition tasks to negative infant expressions had larger amplitudes
[13] while neglectful mothers in a separate study had attenuated LPP amplitudes to all
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emotional infant faces [94]. Similar to the N170, characteristics of the P300 and LPP
also appear to be modulated by individual differences, such as the desirability or

preference for the stimuli, parental status, anxiety, and early childhood experiences

[93], [97], [100], [101].

Taken together, the N170, P300, and LPP embody different processing modalities of

infant cues, with the former representing earlier, more automatic perception and the
latter representing higher-order cognition. Newer evidence suggests that face

processing may be influenced by the affective significance of the stimuli and therefore
interact with emotion or reward systems [102]; a few imaging studies show an

interaction between the fusiform gyrus and the amygdala or orbitofrontal cortex

during face viewing [65], [102]. Although dopamine and norepinephrine have been
implicated in the manifestation of the P300 and LPP [97], there are a few studies

exploring neurohormonal involvement with other ERP responses. Oxytocin, with its
reported roles in attention allocation for faces and emotional events, may be an

integral molecular modulator of these neural responses particularly with regard to

affiliative stimuli.

In the second part of this thesis, we performed an ERP analysis on the N170, P300, and
LPP components, employing neutral and distressed infant and adult faces with non-

social stimuli (houses) as a control. Given OT’s aforementioned properties in social

behavior, it was expected that OT administration would increase sensitivity to faces
compared with houses, and emotional compared with neutral faces. A prior study

showed that mothers with certain alleles of the OT receptor gene have earlier latencies
for the N100 (a negativity differentiating emotional facial expressions) only in
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response to infant faces [13]. Other studies showed that elevated P300 amplitudes

were directly associated with OT levels in foster parents viewing photos of their child
[103], while OT administration led to larger LPP amplitudes with emotional faces

[100]. As such, it was hypothesized that OT administration would increase both the
early N170 component and the later P300 and LPP amplitudes in our cohort of

nulliparous women. Specifically, we hypothesize that OT will further increase the

amplitudes of the N170 and P300 for infant compared with adult faces, and LPP for
distressed faces compared with neutral faces.
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STATEMENT OF PURPOSE
Aim:
The specific aim of this thesis is to determine how OT affects (1) resting-state neural
oscillations and (2) event-related potentials in response to social stimuli in healthy,

nulliparous women.
Hypotheses:

Intranasal OT administration will:

(1) Decrease delta-beta coupling in participants at rest without affecting the activity
of the individual delta and beta frequency bands

(2) Increase sensitivity of the participants to social stimuli as compared to placebo,
measured as increased amplitudes of the:

a. N170 to infant faces compared with adult faces

b. P300 to infant faces compared with adult faces

c. LPP to emotional (distressed) faces compared with neutral faces
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METHODS
Note: Helena Rutherford (HR) and Linda Mayes (LM) designed the experiments and

trained me (XMG), Nathan Hayes (NH), and Kelsey Graber (KG) on all protocols. NH and
KG performed the telephone eligibility screening. XMG, NH, and KG conducted the visits
and ran the participants through the face-viewing tasks. XMG and HJVR analyzed the
data and HJVR performed the statistical analyses.
Participants

Twenty-six healthy, nulliparous women from the Yale University and New Haven

community were recruited using flyers for two study visits scheduled four weeks apart
to facilitate continuity in menstrual cycle phase. Eligibility was assessed by telephone

screening and exclusion criteria included pregnancy, use of any hormonal birth control,
clinically significant medical or psychiatric illnesses, and use of psychotropic
medications. A full list of inclusion/exclusion criteria are listed in Table 1.

All participants gave informed consent during the first visit and were compensated $80
for each visit ($160 total). Two participants did not return for a second visit and the

data from one participant could not be analyzed due to excessive artifacts. Therefore,

the final sample consisted of 23 nulliparous women (22 single, 1 married), aged 18 – 31
years (M=23.3; SD=3.3). Using self-reported menstrual data, half of the participants

were in the luteal phase of their menstrual cycle. All were high school graduates

(M=16.7 years of education; SD=2.0). Self-identified ethnicity was: Caucasian/White

(n=14), Asian-American/Asian (n=5), African-American/Black (n=1), Hispanic/Latina

(n=1) and Other (n=2). One participant reported current cigarette use, and two
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reported current marijuana use; no participants had present or past alcohol or

substance abuse as gauged by the Addiction Severity Index Lite CF [104] interview.
Table 1. Inclusion and exclusion criteria used for telephone screening of participants
Inclusion Criteria

•
•
•
•

Adults ages 18-64
Good medical health
Ability to understand
and speak English
Nulliparity

Exclusion Criteria

•

•

•

•

Procedure

Medical Illnesses:
o Moderate or severe acute or chronic medical illnesses
(e.g. cardiac disease, diabetes, epilepsy, influenza).
Cardiovascular risk factors:
o History of hypertension with baseline blood pressure
above 140 mm Hg (systolic) over 90 mm Hg (diastolic)
o Any history of syncope and/or baseline blood pressure
below 100 mm Hg (systolic)
CNS disease:
o Known history of brain abnormalities (e.g.,
neoplasms, subarachnoid cysts), cerebrovascular
disease, infectious disease (e.g., abscess), or other
central nervous system disease
o History of head trauma that resulted in a persistent
neurologic deficit, or loss of consciousness > 3
minutes
Medication status:
o The use of contraceptive hormones
o The use of any psychotropic medications excluding
those individuals on stable doses of a neuroleptic
and/or an antidepressant medication for at least the
past 6 weeks

All procedures were approved by Yale School of Medicine Human Investigation

Committee (HIC: 1309012677) and registered under clinicaltrials.gov (Identifier:

NCT02238379). Both visits occurred between 1200h and 1500h in order to minimize
diurnal variations in hormone levels, with attempts to schedule the participant at the

same time on both days [105]–[107]. Participants refrained from exercising and alcohol
use for 24 hours, caffeine intake for 12 hours, and smoking and eating for two hours

before each visit. Upon arrival, participants had their blood pressures measured and

completed pregnancy, urine drug, and breath alcohol and carbon monoxide testing. No
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participants were pregnant or evidenced recent substance use in their urine toxicology
or breathalyzer tests.

Given the intranasal route of the spray administration, participants filled out a nasal

questionnaire (www.nwentallergy.com) to document the presence and severity of

symptoms such as nasal congestion and itching. All participants had minimal symptoms,
with total scores of less than four (out of 15) during their first visit and with one

participant scoring six during the second visit due to a recovering upper respiratory

illness. Moreover, participants completed various personality questionnaires including
the State-Trait Anxiety Inventory (STAI) [108], the Beck Depression Inventory-II (BDI)
[109], the Perceived Stress Scale (PSS) [110], and the Parental Bonding Instrument

(PBI) [111] during each visit (Table 2). The only statistical difference found was for
State Anxiety, with participants scoring lower on the visits where they received OT
compared to placebo sprays (M=30.8, SD=7.2 versus M=34.7, SD=10.9; p=0.03).
However, both scores lay well below the cutoff for clinically significant anxiety

symptoms, and Trait Anxiety was not statistically different between conditions. Finally,
routine safety monitoring with blood pressure, heart rate, and temperature
measurements was conducted throughout the visit.

In this double-blind, within-subject crossover design, participants received, at random

and counterbalanced, either OT (United States Pharmacopeia) or a placebo delivered by
nasal spray. Both substances were in identical bottles and prepared by the

Investigational Pharmacy at Yale-New Haven Hospital. After priming the bottle,

participants administered four puffs of spray, alternating nostrils with 15 seconds

between puffs, of 4 IU/puff resulting in a total dose of 24 IU. This OT dosage was chosen
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because of there being no adverse behavioral and neurobiological effects in previously

reported intranasal administrations [112]. The placebo spray contained all ingredients
except the active OT. In post-experiment interviews, participants were unable to

identify better than chance whether they received the OT (n=4 guessed correctly) or

placebo (n=5 guessed correctly) spray. After a 45 minute rest period, participants first
completed the ERP Experiment lasting 25 minutes, followed by the EEG Experiment

(described below). Each visit lasted approximately two hours, with both visits having
the same procedural flow.

Table 2. Mean scores and standard deviation (SD) for questionnaires completed by participants on
separate visits prior to nasal spray delivery. Paired two-tailed t-tests were used to calculate p-value
for comparison between conditions if appropriate.
Questionnaire

Placebo

Oxytocin

p-value

4.3 (SD=5.9)

17.0 (SD=8.0)

0.93

State-Trait Anxiety Inventory c

17.7 (SD=7.3)‡

4.1 (SD=6.2)

State Anxiety

34.7 (SD=10.9)

30.8 (SD=7.2)

0.03

Beck Depression Inventory a
Perceived Stress Scale b

Trait Anxiety

Parental Bonding Instrument d

30.3 (SD=7.6)

29.9 (SD=7.9)

Maternal Care

29.6 (SD=6.8)

Maternal Protection

13.2 (SD=7.9)

Paternal Care†

Paternal Protection†

0.31

0.79

27.7 (SD=8.8)
11.1 (SD=8.8)

†1 participant did not report paternal care or protection scores
‡1 participant had incomplete questionnaire

Scores <13 indicate minimal depression
Scores of 16-20 indicate slightly higher than average stress
c Scores >40 suggest clinically significant anxiety symptoms
d Optimal parenting is defined as high care (maternal>27, paternal>24) and low protection
(maternal<13.5, paternal<12.5). Reported data are averaged from both visits.
a

b
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EEG Acquisition
All data were collected in a sound-attenuated room under low ambient light conditions.

A 128 Hydrocel Ag/AgCl electrode sensor net (Electrical Geodesics, Inc.; Tucker, 1993)

was soaked in a warm potassium chloride solution and fitted according to manufacturer
specifications evenly and symmetrically across the participant’s scalp from nasion to
inion and from the left to right ear. Continuous EEG was recorded using Net Station

4.2.1 with a sampling rate of 250 Hz and high impedance amplifiers (Net Amps 200,

0.1Hz high pass, 100Hz low pass). Electrodes were referenced to the vertex (Cz) during
EEG recording and impedances were kept below 40 kΩ.

EEG Experiment

After the ERP Experiment and approximately 70 minutes after intranasal

administration of OT or placebo sprays, participants completed a resting state eyes-

open eyes-closed EEG task. This task consisted of a continuous series of six one-minute

recording periods as participants sat quietly in alternating eyes-open (EO) and eyesclosed (EC) conditions (i.e. OCOCOC).
ERP Experiment

Participants were asked to sit quietly for 45 minutes after administration of either the
OT or placebo spray with blood pressure and heart rate monitored throughout. The

experimental task began with nine practice trials containing stimuli not included in the
experiment (photographs of farmyard animals) following the same protocol as the

experimental trials. The trial sequence consisted of a central fixation cross (jittered
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between 400 – 600ms), stimulus presentation (1000ms), and a blank screen (1000ms).
All stimuli were randomly selected and presented on a uniform black background.

Experimental stimuli were grayscale photographs of 12 unique infant faces, 12 unique
adult faces, and 24 unique houses. With identity held constant, half (6) of the faces in

each group for both infants and adults showed distressed expressions while the other

half (6) showed neutral expressions. Pre-tests were conducted using all the face stimuli
to confirm their emotional content.

Each participant completed four blocks of 108 experimental trials. Within each block,

48 face stimuli (50% of the faces were infants; 50% of the expressions were distressed)
and 48 house stimuli were presented. In order to assure participant attention, an
additional 12 catch trials requiring a key press response were included in each

experimental block, but were not included in the final analysis. In total there were 192

house trials and 192 face trials (48 Adult Distress, 48 Adult Neutral, 48 Infant Distress,

and 48 Infant Neutral). The face-viewing experiment took approximately 25 minutes to

complete.

Data Analysis
All analyses were performed blind the spray condition of each participant. Net Station
4.5 was used to pre-process all raw EEG data and prepare the data for statistical

analysis. Secondary analyses of any interactions between the self-report questionnaires

(i.e. STAI, PSS, BDI, PBI) and EEG data will be conducted in a follow-up study and are not

reported below.
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EEG Experiment
To analyze EEG data during the resting conditions, the data was segmented into twosecond epochs, yielding 90 possible epochs for each of the EO and EC conditions.

Artifact detection was 200μV for bad channels and Ocular Artifact Removal (OAR;

[113]) using a blink slope threshold of 14μV/ms was applied to the EEG data. Eye blink
and movement threshold was set to 150μV. Spline interpolation was used to replace

channels with artifacts in more than 40% of trials. EEG data were then re-referenced to

the average reference of all electrodes and baseline-corrected. Following pre-

processing, there were on average 73 (range: 34-90) EO epochs and 78 (range: 36-90)

EC epochs (t(48)=-2.03, p=.048).

Data were exported to Matlab 7.9.0 (R2009b MathWorks, Natick, MA) where Fast

Fourier Transform analyses were performed. The average spectral power for delta

(0.5–4Hz) and beta (13–25Hz) frequencies were extracted and natural log transformed
(ln) given their non-normal distributions. Subsequent statistical analyses were

performed on the correlation between the ln power of delta and beta frequencies and
averaged across electrodes sites in: central (C3, C4, Cz), prefrontal (Fp1, Fp2), frontal

(F3, F4, F7, F8, Fz), parietal (P3, P4, Pz), temporal (T3, T4, T5, T6), and occipital (O1, O2)
regions (consistent with the 10-20 electrode system; Jasper, 1958; Figure 3D). Ln delta

and beta power were also compared when averaging across all electrode sites. Although
spectral data from EO and EC conditions are often averaged together to represent a
single resting state condition, we compared the ln delta and beta power within and

between EO and EC conditions given differences that have been reported previously
between these two resting EEG conditions [114], [115].

23

Next, Steiger’s [116] modification of Dunn and Clark’s [117] z score was used to test for
differences between two non-overlapping dependent correlations [118], and 95%
confidence intervals were calculated [119]. Given the directional hypothesis of

decreased delta-beta correlations associated with OT, one-tailed tests were employed.

Effect size is presented as partial eta-squared (η2partial), where .01 represents a small
effect size, .06 represents a medium effect size, and .14 represents a large effect size

[120]. Greenhouse-Geisser corrections were used when sphericity assumptions were

violated.

ERP Experiment
For data processing to analyze the ERPs, each EEG file was first digitally filtered with a

30 Hz low-pass filter for reduction of environmental noise artifacts. The EEG signal was
subsequently segmented into one-second epochs, beginning 100 ms before and ending
900 ms after the onset of the stimulus. Spline interpolation was used to replace

electrode channels with artifacts in more than 50% of the trials and OAR using a blink

slope threshold of 14 µV/ms was also applied to all data.

Electrode clusters as they cover the scalp are presented in Figure 1. Electrodes of

interest were selected for the N170 using scalp regions characteristically eliciting the

N170 [121], and conforming to electrode sites used in published dense-array EEG face
perception studies [50], [122]. These electrode sites consisted of two clusters of six

electrodes over the left lateral posterior scalp (58 59, 64, 65, 68, and 69) and the right

lateral posterior scalp (89, 90, 91, 94, 95, and 96). Data for ERP analysis were averaged
across the six sites in each hemisphere. The N170 time window was derived and

customized for each participant using the Net Station user-defined event function; this
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enabled statistical extraction of each component and ensured they were representative

of waveform variability. Specifically, the N170 that was extracted for statistical analysis
was identified and marked as an event at each electrode site per participant. The time

window ranged across participants from 150 ms to 225 ms, with the N170 peak defined
as the minimum amplitude falling in that window.

Figure 1. Electrode array layout with clusters of interest highlighted (top of figure is nasion). N170
(Circled) = Left hemisphere: 58 59, 64, 65, 68, 69; Right hemisphere: 89, 90, 91, 94, 95, 96. P300/LPP
(Shaded) = 61, 62, 67, 72, 77, 78.
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For the P300 and the LPP, ERP data were averaged over six electrode sites typically
used in P300 research (61 62, 67, 72, 77, and 78; [99], [123]) that also overlap with

published dense-array LPP research [100], [101]. Using time windows of 200 to 400 ms
and 500 to 800 ms after stimulus onset, we measured the mean amplitudes of the P300
and the LPP, respectively. Next, the P300 and LPP were both examined in the averaged

data of each participant to confirm that the component of interest was captured at each
electrode site. Finally, the mean amplitudes were statistically extracted for each
participant.

Statistical analysis was performed using repeated measures of analysis of variance

(ANOVA). All data were also assessed for their appropriateness for parametric analyses
and house stimuli were separately analyzed from face stimuli for all components.
Similar to the EEG Experiment, effect size is presented as η2partial.

The N170 data for houses were analyzed with a two (spray: OT, placebo) by two

(hemisphere: left, right) within-subject ANOVA while faces were analyzed using a two

(spray: OT, placebo) by two (face: infant, adult) by two (emotion: distressed, neutral) by
two (hemisphere: left, right) within-subject ANOVA. For both the P300 and LPP, a twotailed paired t-test was conducted to assess the effect of OT versus placebo

administration on house stimuli; a two (spray: OT, placebo) by two (face: infant, adult)

by two (emotion: distressed, neutral) within-subject ANOVA was conducted for face

stimuli. Of note, one participant was excluded as an outlier for LPP analyses following
boxplot assessments.

Figure 2. Delta and beta power for each resting condition (eyes open, eyes closed, and averaged eyes open and closed) and spray
type (OT, placebo). Note: Separate power scales are used for delta and beta maps.
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RESULTS
EEG Experiment
Delta and beta powers
Scalp topographies for the raw delta and beta powers across each of the experimental
conditions (EO, EC, EOEC) are presented in Figure 2. The ln power for each electrode,

resting condition, and spray condition were first separately examined (Table 3) and
found to have no main effect of spray for either delta [F(1,22)=1.48, p=.24,

η2partial=.06] or beta [F<1] frequencies. This confirmed that resting delta and beta
were unaffected by OT administration relative to placebo.

Table 3. Natural log transformed delta and beta power for each electrode site (including a total
power averaged across sites) as a function of resting EEG condition (eyes open, eyes closed) and
spray type (OT, placebo).
Electrode Site

Prefrontal

Frontal

Central

Parietal

Temporal

Occipital

Total

Delta-Oxytocin

1.97

1.06

0.50

0.95

0.67

1.01

0.96

Beta-Oxytocin

-1.95

-2.90

-2.56

-2.74

-1.99

-2.55

Eyes Open

-2.07

-2.64

Delta-Oxytocin

1.57

0.88

0.36

0.71

0.62

0.83

0.78

Beta-Oxytocin

-1.68

-2.70

-3.09

-2.92

-2.95

-2.38

-2.71

Eyes Closed

Delta-Placebo
Beta-Placebo

Delta-Placebo
Beta-Placebo

1.88

1.50

-1.77

0.86

-2.72

0.65

-2.76

0.48

-2.84

0.36

-3.08

0.81

-2.54

0.48

-2.95

0.41

-2.86

0.37

-3.06

0.80

-2.19

0.65

-2.56

0.80

-2.61

0.61

-2.78
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There was a main effect of resting EEG condition for both delta [F(1,22)=10.80, p=.003,
η2partial=.34] and beta [F(1,22)=13.29, p=.001, η2partial=.38], with greater power
during EC relative to EO. For delta, there was a main effect of electrode site

[F(3,76)=40.06, p<.001, η2partial=.65], with greater delta in prefrontal and parietal

regions and lower delta in central regions. These main effects were qualified by resting
condition and electrode site interaction [F(3,62)=7.52, p<.001, η2partial=.26], showing

variability in the magnitude of delta during EO and EC conditions (with this difference
being smallest in temporal electrode sites). There was also a main effect of electrode

site for beta [F(5,110)=30.85, p<.001, η2partial=.58], with greater power in prefrontal,
parietal and temporal regions. Similarly, these main effects were qualified by a resting
condition and electrode site interaction [F(2,40)=36.19, p<.001, η2partial=.62] where
beta was greater in EO and EC conditions in prefrontal regions but greater in EC than
EO conditions in other regions.

There were no other interactions between these variables [F’s<1] for either delta or

beta. Taken together, these data illustrate how delta and beta vary as a function of the
resting EEG condition as well as the electrode site where these frequency bands are

recorded. Critically, delta and beta powers did not differ as a function of OT or placebo
administration.

Cross-frequency coupling
Delta-beta correlations were next examined between OT and placebo conditions. Figure
3 depicts delta-beta correlations for EC (Panel A), EO (Panel B), and EOEC averaged

together (Panel C).
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Figure 3. Delta-beta correlations for placebo and OT conditions at each electrode region (listed on
the horizontal axis) for the Eyes Closed condition (Panel A), Eyes Open condition (Panel B), and
Averaged Eyes Open and Closed conditions (Panel C). Schematic of position and naming of electrodes
using the 10-20 EEG system (Panel D). *Statistical reduction in delta-beta correlation between OT
and placebo conditions (p<.008; corrected for multiple comparisons); Fp=Prefrontal; F=Frontal;
C=Central; T=Temporal; P=Parietal; O=Occipital
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In the EC condition, OT administration resulted in decreased delta-beta correlation

across all electrode sites relative to placebo [z=3.25; p < .01; 95% CI: 0.21–0.99].

Examining individual electrode locations separately, delta-beta correlations were

differentiated by spray condition at prefrontal [z=1.69; p<.05; 95% CI: -0.66–0.88],

frontal [z=2.14; p<.05; 95% CI: 0.03–0.75], parietal [z=2.80; p<.01; 95% CI: 0.12-0.81],

temporal [z=2.58; p<.01; 95% CI: 0.10–0.88], and occipital [z=1.71; p<.05; 95% CI: -

0.06–0.80] sites. Central electrode sites did not show a condition difference [z=0.99;
p=.16; 95% CI: -0.19–0.60]. Notably, after Bonferonni correction for multiple

comparisons across each site (p<.008), only comparisons between parietal and
temporal sites remained statistically significant.

The EO condition had a similar trend for decreased delta-beta correlation after OT

administration, although no individual electrode site reached statistical significance
[z’s<1.15; p’s>.12]. After averaging EOEC together as done in prior research, OT
administration significantly decreased the global delta-beta coupling across all

electrode sites [z=2.15; p .02; 95% CI: 0.04–0.92]. However, there was no condition

difference at individual electrode sites or after correcting for multiple conditions (NB:

parietal [z=2.28; p<.05; 95% CI: 0.05–0.77] and temporal [z=1.69; p<.05; 95% CI: -0.06–
0.82] sites approached statistical significance).

In summary, intranasal OT administration decreased the resting state EEG delta-beta

correlation in the averaged EOEC condition, but predominantly affected the EC
condition.
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ERP Experiment
N170
The N170 amplitude for houses showed no main effect of spray (F<1), hemisphere

[(F(1,23)=2.36, p=.14, η2partial=.04], or their interaction (F<1). For faces, there was a
main effect of emotion [F(1,23)=11.38, p=.003, η2partial =.33] and face type

[F(1,23)=5.11, p=.034, η2partial=.18], but no main effect of spray [F(1,23)=1.06, p=.31,
η2partial =.04], hemisphere (F<1), or any interactions (p’s >.14). Of note, the mean

N170 amplitude was attenuated for houses (M=-1.15 mV; SD=1.34) compared with all

face types, regardless of expression (Infant M=-3.46 mV, SD 2.40; Adult M=-3.27 mV, SD
2.13).

Figure 4. Mean P300 amplitudes for adult and infant face stimuli after placebo and OT
administration. * Mixed effects within subject ANOVA showed main effect of face (p=.03) and Face x
Spray interaction (p=.03).
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P300
A paired t-test comparing mean P300 amplitude for houses after placebo or OT showed
no significant difference [t(23)=-1.41, p=.17]. For face stimuli, the P300 amplitude was

modulated by face type [F(1,23)=5.21, p=.03, η2partial=.19], which was qualified by a

face x spray interaction, [F(1,23)=5.20, p=.03, η2partial=.18]. There was no main effect
of spray [F(1,23)=1.75, p=.20, η2partial =.07] or emotion (F<1). Figure 4 shows the
mean P300 amplitude for each face type and spray condition, depicting how OT

administration selectively led to an increased P300 for infant faces compared with adult
faces.
LPP

A paired t-test comparing mean LPP amplitudes for houses showed no significant

difference between the placebo and OT conditions [t(22)=1.12, p=.27]. There were also
no main effects of spray, face type, emotion or their interactions for the face stimuli
(p’s>.05).
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DISCUSSION
Despite the large number of social cognition and behavioral studies that have employed
intranasal OT administration, the neural mechanisms modulated by this neuropeptide
remains elusive and not well understood. In this present study, the influence of

intranasal OT was assessed using electroencephalography in a group of healthy,

nulliparous women. We examined how OT compared with placebo influenced the

resting state EEG correlations between delta and beta frequency bands, and affected
ERP responses to social and nonsocial stimuli.

During resting state EEG recording, while OT did not modulate the amplitudes of delta

and beta oscillations individually, it did decrease the cross-frequency coupling of delta

and beta across EEG scalp sites. Exploring ERP data, OT administration led to increased

P300 amplitude in response to infant faces as compared to adult faces, without affecting
N170 or LPP amplitudes. Taken together, these findings suggest that a potential

mechanism through which to understand how OT administration modulates attention
allocation for infant cues may be by studying the interrelationships between neural

oscillations; delta-beta represents one such relationship but other oscillations should be
examined as well.

Neural Responses to Oxytocin
To our knowledge, this is the first study to explore how OT administration affects the

correlation between spectral powers. Accumulating research is focusing on

understanding neural network functions through the interactions between fast and
slow wave EEG activity, which are thought to represent cortical and subcortical
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generators, respectively [87]. Indeed, previous research on cross-frequency coupling

have been conducted using cortisol [89] and testosterone [124]; those researchers

similarly observed hormone modulation of cross-frequency coupling without any effect
on individual resting delta and beta frequencies. These findings suggest that the

observed changes in delta-beta correlation may not be due to general neural activity or

arousal changes from the hormone administration, but rather reflect spectral coherence

changes in the underlying neurobiological systems.

As low-frequency oscillations like delta waves are physiologically thought to arise from
subcortical regions while high-frequency oscillations like beta waves are hypothesized
to originate in cortical circuits, the apparent changes in delta-beta correlation may

represent shifts in subcortical-cortical interactions [85]. To date, a majority of research
describes increased delta-beta coupling as associated with anxiogenic contexts and

emotional dysregulation [87], which converges well with OT’s anxiogenic properties

[125]. Interestingly, a few studies suggest that alterations in this coupling are driven by

and are more sensitive to changes in delta activity than beta [87], [88], implying greater
subcortical influences on this relationship. Since slow waves are thought to be involved

in the discrimination of emotional stimuli [126], perhaps changes in delta-beta coupling
reflect changes in emotional salience. One subcortical brain structure that is strongly
involved with emotion—and anxiety—is the amygdala. Converging with this, OT
administration has been shown to alter the functional connectivity between the

amygdala and the bilateral insula and medial and dorsal anterior cingulate cortices in
patients with social anxiety viewing fearful faces [127].
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An advantage of using dense-array EEG methodology is the scalp coverage it provides
despite poor spatial resolution beyond the cortical surface. We found that decreased

delta-beta coupling was more pronounced in the temporal and parietal regions, which

corresponds with fMRI data suggesting that OT effects are the most strongly influenced

and produced the largest effect sizes across research studies in the temporal lobes [38].

These findings correspond with research implicating the temporal regions in the
processing of emotional cues [128]–[131] and the parietal regions in attentional

processing [132], [133]. Furthermore, delta-beta coupling has been suggested to be a

neural correlate of attentional avoidance of threat [134]. Thus, one interpretation of

decreased coupling in temporal and parietal lobes with OT administration may be that
the anxiolytic effects of OT dampen attentional processing of affective stimuli through
modulation of these neural networks.

A strength of the current study is the examination of neural oscillations at multiple

electrode sites, separately and together, for the different resting conditions. We notably

found that although modulation of delta-beta coupling by OT was present when data

from the eyes-closed and eyes-opened recording periods were averaged together as is

typically done in EEG research, it was most prominent in the eyes-closed resting

condition. The physiology behind this phenomenon is not clearly understood, although
studies have shown that there is increased spontaneous activity [115] and generalized
low frequency power increase [114] during EC conditions which may render the

oscillation changes to be more easily visualized. Regardless, it may be valuable to

consider these conditions separately as well as together in future research. Indeed,

except for at the prefrontal electrodes, OT administration led to decreased delta-beta
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coupling at trend-level significance during the eyes-open condition across the scalp,
which may reflect a need for a larger sample size to better elicit this phenomenon.
Oxytocin and Infant Cues

Through capitalizing on the temporal strength of ERPs, we learned how OT may affect

different stages of stimulus processing—from perception and the N170 to attention and
cognition with the P300 and LPP. In our cohort of healthy nulliparous women, the N170

was expectedly attenuated for house compared to face stimuli, and enhanced for infant
faces and distressed expressions compared to adult faces and neutral expressions,

respectively. This is consistent with prior studies showing increased N170 amplitude
with infant faces, particularly those that are distressed [68], [93], [94]. Modulation of

the N170 by face type and emotion is in line with the component’s association with low-

level categorization of visual stimuli, and suggests the importance of efficient
processing of infant faces and the discrimination of distress.

On the other hand, neither the P300 nor the LPP were modulated by emotional

expression. OT administration increased the amplitude of only the P300 component

after participants viewed infant faces compared with adult faces, and did not affect the

amplitudes of the N170 or LPP as was originally hypothesized. Such an outcome implies
that OT mainly affects the temporally later stages of stimulus processing without
changing the initial perceptual processing of the faces themselves. The increased

amplitude of the P300 demonstrates that OT administration was associated with

participants allocating greater attentional resources to infant faces than adult faces. OT
consequently selectively rendered infant faces more salient and relevant, which is

congruent with prior research implicating OT in increasing participants’ sensitivity to

37

infant cues [45] and in the enhancement of the P300 when participants evaluate stimuli

of greater motivational importance [97].

Whereas our results of OT’s effect on resting delta-beta coupling suggested anxiolysis
through a dampening of baseline attentional processes, its effect on the P300

conversely suggested increased attentional allocation to infant stimuli. These seemingly
inconsistent results may be due to resting-state EEG oscillations inherently measuring

different aspects of neuronal processing than ERPs, or can be resolved through the
perspective that OT renders infant cues to be both more salient and less anxiety-

provoking. Further taking into consideration that OT had the greatest impact on delta-

beta correlation in the parietal and temporal lobes, multiple ERP and fMRI studies have
inferred the generation of the P300 to be from an interaction between the frontal and

the temporal-parietal lobes [96], [135]. New research has also shown OT’s ability in
altering the balance of inhibitory and excitatory neurons projecting from the
hypothalamus to the cortex; these connections appear to directly control the

development in virgin mice of a behavioral response to crying pups and subsequent

memory formation for the socially relevant sounds [136]. Altogether, our data supports
a role for OT in modulating neuronal circuitry from subcortical to neocortical regions,
and selectively strengthening resource and attentional allocation to neural processes
that are involved in handling infant cues, while potentially making these cues less
aversive.

The lack of either face, emotion, or OT effect on the LPP was surprising, given its

intimate relationship functionally and electrophysiologically with the P300. Our results

were in contrast to prior research finding greater LPP positivity after OT administration
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in female undergraduates to emotional faces [100]. However, this published study was
predominantly driven by participants reporting lower maternal love withdrawal, and
was affected by oral contraceptive use. The authors suggested that participants with

higher love withdrawal may have maximum facial or emotional processing even under
placebo administration and would not gain the benefit of additional OT [100]. This is

consistent with other research connecting early childhood experiences with OT

sensitivity [15], and may explain why we did not observe an effect without elucidating

and analyzing our participants based on these personal characteristics. Since the LPP
represents a conscious allocation of attention compared to the P300 [97], individual

traits may play a greater role in impacting this component and would be a direction of
future research. Consistent with this idea is a recently published study showing

enhanced LPP in a cohort of mothers shown distressed compared to neutral infant faces
[101], which together with our lack of LPP effect by infant faces in a nulliparous group,
further provides support for a uniquely maternal brain.

Along the same vein, although infant faces elicited stronger N170 amplitudes than adult
faces in our cohort of nulliparous women, OT did not modulate this difference. The

N170 has been shown to be greater in response to infant cues in parents and individuals
in romantic relationships than in individuals who are single or have no children [93],

[137]. Although all our participants have never been pregnant, we did not ask for

relationship status or caregiving experiences which may both play modulating roles.

However, it may be that low-level perceptual or visual processing (represented by the

N170) are simply not affected by OT [138]. In fact, there is some data showing that the
N170 to infant faces is not modulated by parental status [50] or by familiarity of the
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infant to the mother [99]. As such, OT administration may not change early neural
responses to an already salient infant cue.

Limitations and Future Directions

An important limitation to many intranasal OT studies is small sample sizes leading to
underpowered results and low positive predictive values [139]. We strived to offset
this limitation through stringent inclusion and exclusion criteria and a within-

participant experimental design. However, the generalizability of these results to male
participants needs to be established, and future studies using mixed male and female

samples could directly enable between-gender comparisons as well as a replication of
our findings among other female subjects. Moreover, the importance of individual

differences on OT’s influence requires the need for establishing how varying socio-

emotional and personality traits, as well as physiological or pathological states such as
pregnancy or depression, may contribute to its effects (e.g. [140]). Further analysis is

ongoing to examine any interactions between the self-report questionnaires (regarding

anxiety, depression, stress, and early bonding experiences) completed by our

participants and the neuro-electrophysiological data; these results will be explored in a

separate manuscript.

While we found that OT administration did not affect resting delta or beta oscillatory

power, exploring other frequency bands may be worthwhile. Furthermore, although the
difference between relative and absolute power measures is beyond the scope of this

thesis, it is important to note that these measured oscillations of individual frequency
bands represent proportions of multiple frequencies in a recorded EEG, all of which

may be differentially affected (or not) by substance administration. We focused solely
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on delta-beta correlations due to prior research identifying their role in modulating
stress- and anxiety-associated contexts, as well as in interfacing with emotion and

cognition [85], [89], [90], [124]. Indeed, some studies have shown intranasal OT leading

to greater low alpha / mu (8-10Hz) and beta suppression during the viewing of

biological motion [141]. Thus, exploration of OT effects within, as well as across, other

frequency bands and experimental paradigms may be warranted. It is also worth noting
that the analyses we report assumed a linear correlation between the amplitudes of
these oscillations, while other studies have suggested distal brain regions may have

non-linear relationships representing different sets of brain dynamics and functions

[142]. We also only examined amplitude-amplitude synchrony between delta and beta,

in contrast to phase-phase or phase-amplitude measures [143] which can elucidate

other important mechanistic associations of cognitive function (reviewed in [142]).
In regards to the event-related potentials, our results could be further informed by

including faces with positive expressions to compare neural responses to negative and
neutral faces. Since identity and emotional processing of faces are intimately

interlocked [102], we may expect similar results irrespective of emotional valence.

However, multiple studies suggest that infant happiness or distress as represented by

facial expression and cries may activate very different brain regions in parents and nonparents [61], [68], [70]. There is also is a dearth of studies assessing the span of basic
emotions since studies have primarily focused on happy and angry as representation

for positive and negative expressions [25]. For the P300 in particular, we focused on its
amplitude as a whole, instead of separately analyzing its individual temporal

components or its latency. The P3a and P3b subcomponents of the P300 represent
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mechanisms arising from different brain loci [96] and may be differentially affected by
both facial or emotional category and OT administration.

Finally, although EEG arises from neurotransmission and neural activity, it is ultimately

a correlational technique; the precise anatomic origins of our results are not known and
require additional neuroimaging studies aimed towards determining neuroanatomical

and neurophysiological correlates. It is also possible that the commonly used dosage of

24IU intranasal OT is insufficient for delivering an effective cerebral concentration. This
can either, or both, mask any true neurological effects or lead to inaccurate

apportionment of peripherally driven OT effects to central OT activity [22], [139]. The

latter situation is less likely for this thesis given our direct neural measurements using

EEG, but it would be beneficial to conduct dose-response studies and examine whether

these neural relationships are functions of OT levels. Through using varying OT dosages
and measuring saliva OT levels at different experimental time points, we can more

effectively link dynamic hormonal changes with social or electrophysiological behavior.
Conclusion

In summary, the present study explored how intranasal OT administration affected the
neural oscillations and responses to infant faces in a cohort of healthy, nulliparous

women. We demonstrated that OT decreased delta-beta coupling in the resting brain

and increased the amplitude of the P300 as elicited by infant faces compared with adult
faces. This provides a potential mechanism through which intranasal OT may modulate
brain and social behavior on a neural level, and supports the value of EEG in examining
the integration of dynamically changing cortical and subcortical neural networks. By

measuring cross-frequency correlations, we were able to explore the complex
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interactions that OT modulates between subcortical and cortical brain regions, while

the use of ERP further provided us the ability to identify the processing stage at which

OT influences the handling of affiliative stimuli. Overall, this thesis adds to the

intranasal OT literature a potential tool for measuring OT action with delta-beta
coupling, and provides new data on how OT acts upon the female brain.
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